WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003002106) USE OF TYROSINE KINASE INHIBITIONS FOR TREATING ALLERGIC DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/002106    International Application No.:    PCT/IB2002/003297
Publication Date: 09.01.2003 International Filing Date: 28.06.2002
IPC:
A61K 31/00 (2006.01), A61K 31/015 (2006.01), A61K 31/095 (2006.01), A61K 31/40 (2006.01), A61K 31/403 (2006.01), A61K 31/404 (2006.01), A61K 31/415 (2006.01), A61K 31/4709 (2006.01), A61K 31/498 (2006.01), A61K 31/505 (2006.01), A61K 31/506 (2006.01), A61K 31/517 (2006.01), A61K 31/519 (2006.01), A61K 31/66 (2006.01), A61K 45/06 (2006.01)
Applicants: AB SCIENCE [FR/FR]; 3, avenue George V, F-75008 Paris (FR) (For All Designated States Except US).
MOUSSY, Alain [FR/FR]; (FR) (For US Only).
KINET, Jean-Pierre [FR/US]; (US) (For US Only)
Inventors: MOUSSY, Alain; (FR).
KINET, Jean-Pierre; (US)
Agent: MARTIN, Jean-Jacques; Cabinet Régimbeau, 20, rue de Chazelles, F-75847 Paris Cedex 17 (FR)
Priority Data:
60/301,408 29.06.2001 US
Title (EN) USE OF TYROSINE KINASE INHIBITIONS FOR TREATING ALLERGIC DISEASES
(FR) UTILISATION D'INHIBITEURS DE TYROSINE KINASE DANS LE TRAITEMENT DE MALADIES ALLERGIQUES
Abstract: front page image
(EN)The present invention relates to a method for treating allergic diseases such as asthma, comprising administering a tyrosine kinase inhibitor to a human in need of such treatment, more particularly a non-toxic, selective and potent c-kit inhibitor. Preferably, said inhibitor is unable to promote death of IL-3 dependent cells cultured in presence of IL-3.
(FR)L'invention concerne une méthode de traitement de maladies allergiques, telles que l'asthme. Cette méthode consiste à administrer un inhibiteur de tyrosine kinase à un être humain nécessitant un tel traitement, plus précisément un inhibiteur de c-kit non toxique, sélectif et puissant. Ledit inhibiteur est, de préférence, incapable de favoriser la mort de cellules dépendantes de IL-3 cultivées en présence de IL-3.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)